Speak directly to the analyst to clarify any post sales queries you may have.
Glucose Monitoring Devices Market - Overview
The increasing incidence of diabetes and rising awareness about the self-management of diabetes is fueling the growth of the global glucose monitoring devices market. The changing lifestyle, high alcohol consumption, and smoking habits are some of the major factors attributing to the rising number of diabetic patients across the globe. The lucrative reimbursement policies in developed countries such as the US and the UK is enhancing the adoption rate of these medical devices in the market.
The introduction of advanced glucose monitoring devices will transform the medical devices market and promote the development of new product portfolios. The introduction of medical devices that are compatible with smartphones and smart gadgets is offering easy access to these devices to a large number of end-users in the global market. The integration of glucose monitoring devices with mobile applications has eased the monitoring of blood glucose levels amongst patients.
The collaborative partnerships among vendors and end-users to develop and promote the use of pocket-friendly glucose monitoring devices at home healthcare settings will contribute to the demand for these medical devices in the market. The growth of e-commerce websites will create effective distribution networks for vendors in the global market. The glucose monitoring devices market is anticipated to generate revenues of over $6 billion and is projected to grow at a CAGR of more than 8% during the forecast period.
Glucose Monitoring Devices Market - Dynamics
The growth of emerging economies such as China, India, and Singapore are creating new opportunities for vendors in the global glucose monitoring devices market. Leading companies such as Medtronic are launching diabetes awareness campaigns in the APAC region to increase the use of CGM systems for diabetic patients and gain a larger market share. Collaborations among key players and hospitals and diagnostic clinics will increase the adoption of these medical devices in the market and help launch innovative products to meet the growing demand in the region. Additionally, the rapidly changing regulatory policies and lucrative investment policies will enable leading players from the global market to invest in the development of the glucose monitoring devices market in these regions over the next few years.
Glucose Monitoring Devices Market Segmentation
This market research report includes a detailed segmentation of the market by products, by end-users, by distribution channels, and by geography.
Glucose Monitoring Devices Market - By Products
High demand for SMBG devices from developed countries such as the UK, the US, and Germany attributes to market share in this segment.
The glucose monitoring devices market by products is segmented into self-monitoring blood glucose devices and continuous glucose monitoring devices. The self-monitoring blood glucose devices were the largest product segment in the market accounting for close to 58% of the total market share in 2017 and are expected to grow at an impressive CAGR over 10% during the forecast period. The advent of home healthcare and growing need for daily monitoring of blood sugar level in an individual is driving the growth of this market segment in the global market. The three primary sub-segments of self -monitoring blood glucose devices segment are blood glucose strips, glucose meters, and lancets.
Glucose strips are the most popular SMBG devices used in the global market. The rising awareness about self-monitoring of glucose, diabetes management, and prevention of diabetes are some of the factors that will contribute to the demand for SMBG devices during the forecast period.
Glucose Monitoring Devices Market - By End-Users
Hospitals and clinics to dominate the glucose monitoring devices market during the forecast period.
The end-users segment in the glucose monitoring devices market is classified into hospitals and clinics, diagnostic centers, and home healthcare. Hospitals and clinics dominated the global market by accounting for around 40% of the total market share in 2017. The use of the conventional method of glucose monitoring is highly preferred amongst the geriatric population and is one of the factors driving the growth of this market segment. Hospitals help with the diagnosis and monitoring of blood glucose level and other abnormalities resulting due to improper glucose concentration in the blood. The number of specialized services provided by small hospitals and clinics is attributing to the popularity of this market segment in the global market. The level of accuracy of the test result, consultation, and medication are some of the factors that augment the growth of the hospitals and clinics in the glucose monitoring devices market.
Glucose Monitoring Devices Market - By Distribution Channels
Retail stores control a larger market share in the glucose monitoring devices market.
The glucose monitoring devices market by distribution channels is categorized into retail and online. Retail stores were the largest distribution channel segment in the global market occupying around 55% of the total market share. The retail segment is further divided into specialty stores, drug stores, and pharmacies. The wide availability of advanced glucose meters and affordable devices at a varied price range and for home healthcare set up is driving the growth of the retail stores segment. Retail stores also focus on marketing the product off-the-shelf targeting customers that help in increasing the brand awareness and creates demand for the medical devices in the global market.
Glucose Monitoring Devices Market - By Geography
North America is the most significant revenue contributor to the glucose monitoring devices market.
The geographical segment of the glucose monitoring devices market is divided into APAC, Europe, Latin America, MEA, and North America. North America dominated the global market occupying around 40% of the total market share in 2017 and is anticipated to grow at a CAGR of over 9% during the forecast period. The US and Canada are the primary revenue contributors in the market in North America. The effective reimbursement policies and growing awareness of diabetes are driving the demand for glucose monitoring devices in North America. The increasing investments in the R&D and prevalence of technologically advanced medical device markets in the region will help North America led the global market during the forecast period.
Key Countries Profiled
The key countries profiled in the report are:
- US
- Canada
- Germany
- UK
- China
- Japan
- Australia
- Brazil
- Mexico
- South Africa
Key Vendor Analysis
The glucose monitoring devices market is highly fragmented with the presence of various international players. The rapidly changing technological environment and high investment in R&D are intensifying the competition in the global market. The leading vendors in the market are focusing on launching glucose monitoring devices with high accuracy and that are compatible with mobile applications. The key players are also focusing on diversifying their businesses across various regions to gain a larger consumer base and gain a larger market share.
The major vendors in the global market are:
- Abbott
- Medtronic
- LifeScan
- Roche
Other prominent vendors include: 77 Elektronika, A. Menarini Diagnostics, ACON Laboratories, AgaMatrix, Alere, Ascensia Diabetes Care, B. Braun, Beurer, Bioptik Systems, DiamonTech, Dexcom, Echo Therapeutics, Glysens, HemoCue, iHealth Labs, Innovus Pharmaceuticals, Integrity Applications, International Biomedical, Medisana, Mediwise, National Diagnostic Products, Nemaura Medical, Nipro, Nova Biomedical, Novo Nordisk, Orsense, Panasonic Healthcare, Philosys, Senseonics, TaiDoc Technology, Terumo Europe, and Wama Diagnostica.
Key market insights include:
1. The analysis of glucose monitoring devices market provides market size and growth rate for the forecast period 2018-2023.
2. It offers comprehensive insights on current industry trends, trend forecast, and growth drivers about the glucose monitoring devices market.
3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
4. It offers a complete overview of market segments and the regional outlook for glucose monitoring devices market.
5. The report offers a detailed overview of the vendor landscape, competitive analysis, and key market strategies to gain competitive advantage.
Report Snapshot
According to the latest industry analysis, the global glucose monitoring devices market size is expected to reach over $6 billion by 2023, growing at a CAGR of more than 8% 2017-2023. The market research report provides in-depth market analysis and segmental analysis of the global glucose monitoring devices market by product, distribution channel, end-user, and geography.
Base Year: 2017
Forecast Year: 2018-2023
The study considers the present scenario of the global glucose monitoring devices market and its market dynamics for the period 2018-2023. It covers a detailed overview of various market growth enablers, restraints, and trends. It also covers both demand and supply sides of the market. It profiles and analyzes the leading 4 companies and 32 other prominent companies operating in the market.
Major Vendors in the Glucose Monitoring Devices Market:
- Abbott
- - Business Overview
- - Business Segments
- - Abbott in Global Glucose Monitoring Market
- - Product Offerings
- - Key Strengths
- - Key Strategies
- - Key Opportunities
- Medtronic
- LifeScan
- Roche
Prominent Players in the Glucose Monitoring Devices Market:
- 77 Elektronika
Company Overview
- A. Menarini Diagnostics
- ACON Laboratories
- AgaMatrix
- Alere
- Ascensia Diabetes Care
- B. Braun
- Beurer
- Bioptik Systems
- DiamonTech
- Dexcom
- Echo Therapeutics
- Glysens
- HemoCue
- iHealth Labs
- Innovus Pharmaceuticals
- Integrity Applications
- International Biomedical
- Medisana
- Mediwise
- National Diagnostic Products
- Nemaura Medical
- Nipro
- Nova Biomedical
- Novo Nordisk
- Orsense
- Panasonic Healthcare
- Philosys
- Senseonics
- TaiDoc Technology
- Terumo Europe
- Wama Diagnostica
Market Segmentation by Product
Self-Monitoring Blood Glucose Devices
- Glucose Strips
- Glucose Meter
Lancets
Continuous Glucose Monitoring Devices
Market Segmentation by End-users
- Hospital and Clinics
- Diagnostic Centers
- Home Healthcare
Market Segmentation by Distribution Channels
Retail
- Specialty Stores
- Drug Stores/Pharmacies
Online
Market Segmentation by Geography
North America
- US
- Canada
Europe
- UK
- Germany
APAC
- China
- Japan
- Australia
Latin America
- Brazil
- Mexico
MEA
- South Africa
Table of Contents
Companies Mentioned
- Orsense
- DiaMonTech
- 77 Elektronika
- Abbott
- Glysens
- Novo Nordisk
- Nemaura
- Panasonic Healthcare
- Echo Therapeutics
- Taidoc Technology
- Senseonics
- Alere
- Beurer
- National Diagnostic Products
- Wama Diagnostica
- AgaMatrix
- Dexcom
- Bioptik Systems
- A. Menarini Diagnostics
- Acon Laboratories
- Terumo Europe
- Philosys
- Hemocue
- Integrity Applications
- International Biomedical
- Ascensia Diabetes Care
- Medisana
- Mediwise
- LifeScan
- Roche
- Innovus Pharma
- iHealth Labs
- Medtronic
- B. Braun Melsungen
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...